Medication info
Seoul Terbinafine Hydrochloride Tablets

Seoul Terbinafine Hydrochloride Tablets

Prescription medicationTablet
Ingredient · strength
Terbinafine Hydrochloride›140.625mg / 1 tablet
Manufacturer / importer
Seoul Pharmaceutical Co., Ltd.
Appearance
White round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201903042 · Approved 2019.05.10 · Insurance code 652904390

Summary

Main use
Treatment of onychomycosis, cutaneous fungal infections (such as tinea pedis), and tinea capitis in children
Who uses it
Adults · Children
Adult dosage
Administer 125 mg of terbinafine twice daily or 250 mg once daily. The treatment duration according to condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital or plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Usually administer for 6 weeks~3 months. The treatment duration may be shortened to 3 months or less in cases of infection of the fingernails or relatively small toenails, or in younger patients. A treatment duration of 3 months is usually sufficient for toenail infections, but treatment may take 6 months or longer in some patients. Treatment may take longer in patients with slow nail growth. In patients with creatinine clearance less than 50 mL/min, reduce the daily dose by 1/2.
Children's dosage
Administer to children aged 2 years and older. Use is not recommended for children under 2 years because there is no experience with administration in this age group. Tinea capitis: 4 weeks 1) Body weight under 20 kg (under 5 years): Administer 62.5 mg once daily. 2) Body weight 20~40 kg (5~12 years): Administer 125 mg once daily. 3) Body weight over 40 kg (over 12 years): Administer 250 mg once daily.

Ingredients

Manufacturer
Seoul Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of onychomycosis, cutaneous fungal infections (such as tinea pedis), and tinea capitis in children

  • Dermatophyte infections
  • athlete's foot
  • tinea corporis
  • tinea cruris
  • onychomycosis
  • tinea capitis
View approved original text

This medication is used for the treatment of dermatophyte infections caused by dermatophytes such as athlete's foot, tinea corporis, and tinea cruris in adults, as well as for the treatment of tinea capitis in children.

Dosage and Administration

Adult dosage

Administer 125 mg of terbinafine twice daily or 250 mg once daily. The treatment duration according to condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital or plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Usually administer for 6 weeks~3 months. The treatment duration may be shortened to 3 months or less in cases of infection of the fingernails or relatively small toenails, or in younger patients. A treatment duration of 3 months is usually sufficient for toenail infections, but treatment may take 6 months or longer in some patients. Treatment may take longer in patients with slow nail growth. In patients with creatinine clearance less than 50 mL/min, reduce the daily dose by 1/2.

Children's dosage

Administer to children aged 2 years and older. Use is not recommended for children under 2 years because there is no experience with administration in this age group. Tinea capitis: 4 weeks 1) Body weight under 20 kg (under 5 years): Administer 62.5 mg once daily. 2) Body weight 20~40 kg (5~12 years): Administer 125 mg once daily. 3) Body weight over 40 kg (over 12 years): Administer 250 mg once daily.

Precautions

This medication is not recommended for patients with chronic or active liver disease. It is essential to confirm any liver disease before taking this medication, and regular liver function tests should be conducted. If symptoms of liver dysfunction appear, discontinue the medication immediately and consult a physician. Since this medication may affect liver function, it should be stopped if liver function test results worsen. Additionally, this medication should not be given to patients with hematological disorders, severe renal impairment, children under 2 years old, or breastfeeding women. Patients with lactose intolerance should also avoid this medication. Caution is advised when administering to the elderly, those with reduced kidney function, or underweight children, as severe skin reactions may occur; careful observation is necessary. Discontinue the medication immediately if skin rashes or allergic reactions develop. This medication may cause adverse reactions in various organs including the liver, blood, skin, and muscles; consult a doctor immediately if symptoms arise. Pay particular attention to symptoms such as liver dysfunction, skin rashes, muscle pain, and dizziness. Dizziness and other side effects may occur while driving or operating machinery, so caution is advised. This medication may interact with other drugs, so inform your doctor or pharmacist about any drugs you are currently taking, as dosage adjustments may be necessary when used in combination with some medications. Women who are pregnant or may become pregnant should use this medication with caution, and breastfeeding should be discontinued while using this medication. An overdose may lead to symptoms such as headache, nausea, abdominal pain, and dizziness, so be careful not to exceed the recommended dose. This medication should be kept out of the reach of children and stored at room temperature, away from direct sunlight and moisture.

Side effects

Persistent nausea, decreased appetite, fatigue, vomiting, upper abdominal pain, jaundice, dark urine, loose stools, biliary tract failure, hepatitis, bile stasis, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, lethargy, increased liver enzymes, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, subcutaneous hemorrhage, leukopenia, anemia, rash, itching, photosensitive reaction, skin and mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, blistering dermatitis, psoriatic rash, exacerbation of psoriasis, hair loss, musculoskeletal reactions, arthralgia, myalgia, myalgia, weakness, elevated CPK, elevated myoglobin, rhabdomyolysis, hypotension, respiratory distress, chest tightness, urticaria, erythema, facial swelling, lymphangiectasia, abdominal distension, dyspepsia, mild abdominal pain, diarrhea, upper abdominal discomfort, thirst, vomiting, glossitis, depression, anxiety, headache, taste disturbance, dizziness, drowsiness, sensory abnormalities, sensory reduction, decreased attention, insomnia, elevated BUN, frequent urination, visual impairment, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, increased total cholesterol in blood, increased triglycerides, lethargy, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic dysfunction, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, diminished vision, hearing loss, auditory impairment, vasculitis, permanent anosmia, hyposmia, eosinophilia with systemic symptoms associated with drug rash, pancreatitis, rhabdomyolysis, influenza-like illness, increased serum creatine phosphokinase, headache, nausea, epigastric pain, dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1°C and 30°C to ensure the medication's efficacy is preserved safely over time.

Appearance and packaging

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.